EX-23.1 3 ex_142320.htm EXHIBIT 23.1 ex_142320.htm

EXHIBIT 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report relating to the consolidated financial statements of Nuvectra Corporation and subsidiaries dated March 4, 2019 (which report expresses an unmodified opinion and includes an emphasis-of-matter paragraph relating to the sale of NeuroNexus Technologies, Inc.), appearing in the Annual Report on Form 10-K of Nuvectra Corporation for the year ended December 31, 2018.

 

/s/ Deloitte & Touche LLP

 

Dallas, Texas

May 1, 2019